CR

Chilamkuri Reddy Narendra

Active Director Director DIN 08620433
DIN 08620433 First appointment Dec 2019 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Chilamkuri Reddy Narendra

Data last updated:

Chilamkuri Reddy Narendra is a Director at Medtotes Private Limited (since 2019). The company operates in Information Technology.

DIN 08620433
Primary Designation Director
Industry Information Technology
First Appointment 03 Dec 2019
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medtotes Private Limited U72900TG2019PTC137311
Director03 Dec 20192019Active

Board colleagues of Chilamkuri Reddy Narendra

Directorship timeline

Open interactive timeline →
Medtotes Private Limited
Premium access

Shareholding and investment profile for Chilamkuri Reddy Narendra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chilamkuri Reddy Narendra

Chilamkuri Reddy Narendra currently holds 1 directorship: Medtotes Private Limited (Director, since 03 Dec 2019).

Chilamkuri Reddy Narendra was first appointed on 03 Dec 2019 as Director at Medtotes Private Limited.

The current boards of Chilamkuri Reddy Narendra's companies include Kamal Prasad Peddinti (Medtotes Private Limited), Santhanam Kali Doss (Medtotes Private Limited), Upendra Balaprasad Dubey (Medtotes Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available